Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 1654-1659

  Zaccagni, Hayden ^a   Fried, Justin ^a   Cornell, John ^b   Padilla, Patricia ^a   Brey, Robin L ^a,b  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Adhesion Molecules; Neuropsychiatric Disease; Systemic Lupus Erythematosus

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHOLIPID ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER;

ADULT; AGED; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTICLE; BLOOD; BRAIN VASCULITIS; LONGITUDINAL STUDY; MIDDLE AGED;

ADULT; AGED; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LONGITUDINAL STUDIES; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 2442715490     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1273     Document Type: Review

References (42)

1. Horowitz H, D. Rosenbluth, H. Spiera, S. Putzkin : SLE patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. J. Exp. Med. 176, 565-573 (1992)
2. Brey RL, S. L. Holliday, A.R. Saklad, M.G. Navarrete, D. Hermosillo-Romo, C. L. Stallworth, C. R. Valdez, A.Escalante, I. del Rincón, G. Gronseth, C. B. Rhine, P. Padilla, D. McGlasson: Neuropsychiatric Syndromes in SLE: Prevalence Using Standardized Definitions In the San Antonio Lupus Study of Neuropsychiatric Disease Cohort. Neurology 58, 1214-1220 (2002)
3. Ainiala H, J. Loukkola, J. Peltola, M. Korpela, A. Hietaharju: The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57, 496-499 (2001)
4. Futrell, N, L.R. Schultz, C. Millikan: Central nervous system disease in patients with systemic lupus erythematosus. Neurology 42, 1649-1657 (1992)
5. Kaell AT, M. Shetty, BCP. Lee, MD Lockshin : The diversity of neurologic events in systemic lupus erythematosus. Arch. Neurol. 43, 273-276 (1986)
6. American College of Rheumatology (ACR) ad hoc committee on neuropsychiatric lupus. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum 42, 599-608 (1999)
7. Asherson RA., S.D. Denburg, J.A. Denburg, R.M. Carbotte, N. Futrell: Current concepts of neuropsychiatric systemic lupus erythematosus. Postgrad. Med. J. 69, 602-608 (1993)
8. Kovacs JAJ, M.D. Urowitz, D.D. Gladman: Dilemmas in neuropsychiatric lupus. Rheum. Dis. Clin. North Am. 19(4), 795-813 (1993)
9. Denburg JA, R.M. Carbotte, S.D. Denburg: Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37, 464-467 (1987)
10. Hickey WF: T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254-260 (1991)
11. Raine CS, B. Cannella, A.M. Duijvestijn, A.H. Cross: Homing to the central nervous system vasculature by antigen-specific lymphocytes. II lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab Invest. 63, 476-489 (1990).
12. Rossler K, C. Neuchrist, O. Kitz, D. Kraft, H. Lassmann: Expression of leukocyte adhesion molecules at the human blood-brain-barrier. J. Neurosci. Res. 31, 365-374 (1992)
13. Savage COS, S.P. Cooke: The role of the endothelium system vasculitis. J. Autoimmunity 6, 237-249 (1993)
14. Zabry Z, M.M. Waldschmidt, D. Hendrickson, J. Keiner, L. Love-Homan, F. Takei, M.N. Hart: Adhesion molecules on muring brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55. J. Neuroimmunol 36, 1-11, (1992)
15. Wong D, K. Zis-Dorovini: Upregulation of intercellular adhesion molecule-1 expression in primary cultures of human brain microvascular endothelial cells by cytokines and lipopolysaccharides. J. Neuroimmunol 39, 11-22 (1992)
16. Belmont HM, J. Buyon, R. Giorno, S. Abramson: Upregulation of endothelial cell adhesion molecules characterized by disease activity in systemic lupus erythematosus. Arthritis Rheum. 37, 376-383 (1994)
17. Sharief MK, M.A. Noori, M. Ciardi, A. Cirelli, E.J. Thompson: Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain-barrier damage. J. Neuroimmunol. 43, 15-22 (1993)
18. Baraczka K, T. Pozsonyi, M. Szongoth, K. Nekam, A. Megyeri, Z. Balogh, L. Jakab: A study of increased levels of soluble vascular cell adhesion molecule-1 in the cerebrospinal fluid of patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurol. Scand. 99, 95-99 (1999)
19. Piggot R, C. Power: The Adhesion Molecule Facts Book, Academic Press, Inc., San Diego, CA, 60-63, 74-76, 154-157, 1993
20. Nyberg F, Stephansson E. Elevated soluble E-selectin in cutaneous erythematosus. Advances in Experimental Medicine & Biology 455, 153-159 (1999)
21. Ho CY, CK Wong, E.K. Li, L.S. Tam, C.W.K Lam: Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus. Rheumatology 42, 117-122 (2003)
22. Spronk PE, H. Bootsma, M.G. Huitema, P.C. Limburg, C.G. Kallenberg: Levels of soluble VCAM-1, ICAM-1 and E-selectin during disease exacerbations in patients with SLE. Clin. Exp. Immunol. 97, 439-444 (1994)
23. Sari RA, S Taysi, F. Erdem, O. Yilmaz, S. Keles, A. Kiziltunc, A.R. Odabas , R. Cetinkaya : Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus. Rheumatol Int. 21, 149-152 (2002)
24. Kaplanski G, P. Cacoub C. Farnarier V. Martin, R. Gregoire, A. Gatel, J-M Durand, JR Harle, R. Bongrand, J-C Piette: Increased soluble vascular cell adhesion molecule-1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: Correlations with the severity of thrombosis. Arthritis Rheum 43, 55-60 (2000)
25. Tan EM, A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield, J.G. Schaller, N. Talan, R.J. Winchester: The 1982 revised criteria for the classification of SLE. Arthritis Rheumatol 25, 1271-1277 (1982)
26. Bombardier C, D.D. Gladman, M.B. Urowitz, D. Caron, C.H. Chang, and the committee on prognosis studies in systemic lupus erythematosus: Derivation of the SLEDAI. Arthritis Rheum 35, 630-640 (1992)
27. Gladman D, E. Ginzler, C. Goldsmith, P. Fortin, M. Liang , M. Urowitz, P. Bacon, S. Bombardieri, J. Hanly, E. Hay, D. Isenberg, J. Jones, K. Kalunian, P. Maddison, O. Nived, M. Petri, M. Richter J. Sanchez-Guerrero, M. Snaith G. Sturfelt D. Symmons, A. Zoma: The development and initial validation of the systemic lupus international collaborative clinics/American college of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39, 363-369 (1996)
28. First MB, R.L. Spitzer, M. Gibbon & J.B. Williams: Structured Clinical Interview for DSM-IV axis I disorders (SCID-I/P) (Version 2.0). New York: New York State Psychiatric Institute, Biometrics Research Department. (1996).
29. Reeves D, R Kane, K Winter: Automated Neuropsychological Assessment Metrics (ANAM V3.11a/96) User's Manual: Clinical and Neurotoxicology Subset. (Report No. NCRF-SR-96-01). San Diego, CA: National Cognitive Foundation, (1996).
30. Goel N, T.L. Ortel, D. Bali, J.P. Anderson, I.S. Gourley, H. Smith, C.A. Morris, M. DeSimone, D. Ware Branch, P. Ford, D. Berdeaux, R.A.S. Roubey, D.D. Kostyu, S.F. Kingsmore, T. Thiel, C. Amos, M.F. Seldin: Familial Antiphospholipid Antibody Syndrome Criteria for disease and Evidence for Autosomal Dominant Inheritance. Arthritis Rheum 42(2), 318-327 (1999)
31. Barcellini W, G.P. Rizzardi, M.O. Borghi, F. Nicoletti, C. Fain, N. Del Papa, P.L. Meroni: In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity. Lupus 5, 139-145 (1996)
32. Sfikakis PP, D. Charalambopoulos G. Vayoipoulos, R. Oglesby, G.C. Tsokos: Increased levels of intercellular adhesion molecule-1 in the serum of patients with SLE. Clin. Exp. Rheumatol. 12, 5-9 (1994)
33. Matsuda J, K. Gohchi, M. Gotoh, M. Tsukamoto, N. Saitoh: Circulation of intercellular adhesion molecule-1 and soluble interleukin-2-receptor in patients with systemic lupus erythematosus. European J. Haematol 52, 302-303 (1994)
34. Wellicome SM, P. Kapahi, J.C. Mason, Y. Lebranchu, H. Yarwood, D.O. Haskard: Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin. Exp. Jmmunol 92, 412-418 (1993)
35. Wong CK, C.Y. Ho, E.K. Li, C.W.K. Lam: Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9, 589-593 (2000)
36. Egerer K, E. Feist, U. Rohr, A. Pruss, G-R Burmester, T. Dorner : "Increased serum soluble CD14, ICAM-1, and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus," Lupus 9, 614-621 (2000)
37. Alarcon GS, J.M. Roseman, A.A. Bartolucci, A.W. Friedman, J.M. Moulds, N. Goel, K.V. Straaton, J.D. Reveille: Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease early in its course. LUMINA study group. Lupus in Minority populations: Nature vs. Nurture. Arthritis Rheum 41, 1173-1180 (1998)
38. Harris EN, J.K.H. Chan, R.A. Asherson, V.R. Aber, A.E. Gharavi, G.R.V. Hughes: Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 146, 2153-2156 (1986)
39. Wilson W.A., A.E. Gharavi, T. Koike, M.D. Lockshin, D.W. Branch, J.C. Piette, R. Brey, R. Derksen, E.N. Harris, G.R. Hughes, D.A. Triplett, M.A. Khamashta: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42, 1309-1311 (1999)
40. Del Papa N, L. Guidali, A. Sala, C. Buccellati, M.A. Khamashta, K. Ichikawa, T. Koike, G. Balestrieri, A. Tincani, G.R.V. Hughes & P.L. Meroni: Endothelial cells as target for antiphospholipid antibodies. Arthritis Rheum 40, 551-561 (1997)
41. Pierangeli SS. R.G. Espinola. X. Liu. E.N. Harris: Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circulation Research. 88(2), 245-50 (2001)
42. Egerer K, E. Feist, U. Rohr, A. Pruss, G-R Burmester, T. Dörner: Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 9, 614-621 (2000)